These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29544639)

  • 1. The Ovarian Hyperstimulation Syndrome.
    Blumenfeld Z
    Vitam Horm; 2018; 107():423-451. PubMed ID: 29544639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of ovarian hyperstimulation syndrome.
    Dourron NE; Williams DB
    Semin Reprod Endocrinol; 1996 Nov; 14(4):355-65. PubMed ID: 8988530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevention of ovarian hyperstimulation syndrome.
    Corbett S; Shmorgun D; Claman P; ;
    J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases.
    Gurbuz AS; Gode F; Ozcimen N; Isik AZ
    Reprod Biomed Online; 2014 Nov; 29(5):541-4. PubMed ID: 25246114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
    Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
    Liang IT; Huang HY; Wu HM; Wang HS; Yu HT; Huang SY; Chang CL; Soong YK
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian hyperstimulation syndrome in the 21st century: the role of gonadotropin-releasing hormone agonist trigger and kisspeptin.
    Thomsen L; Humaidan P
    Curr Opin Obstet Gynecol; 2015 Jun; 27(3):210-4. PubMed ID: 25811256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome.
    Lainas GT; Lainas TG; Venetis CA; Sfontouris IA; Zorzovilis IZ; Alexopoulou E; Tarlatzis BC; Kolibianakis EM
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):126-133. PubMed ID: 29105961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology, treatment and prevention of ovarian hyperstimulation syndrome.
    Kwik M; Maxwell E
    Curr Opin Obstet Gynecol; 2016 Aug; 28(4):236-41. PubMed ID: 27273307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney.
    Pereira N; Lekovich JP; Kligman I; Rosenwaks Z
    Gynecol Endocrinol; 2017 Aug; 33(8):593-597. PubMed ID: 28440686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline.
    ;
    Fertil Steril; 2016 Dec; 106(7):1634-1647. PubMed ID: 27678032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.
    Mai Q; Hu X; Yang G; Luo Y; Huang K; Yuan Y; Zhou C
    Am J Obstet Gynecol; 2017 Jan; 216(1):42.e1-42.e10. PubMed ID: 27555316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian hyperstimulation syndrome.
    Budev MM; Arroliga AC; Falcone T
    Crit Care Med; 2005 Oct; 33(10 Suppl):S301-6. PubMed ID: 16215351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.
    O'Neill KE; Senapati S; Maina I; Gracia C; Dokras A
    J Assist Reprod Genet; 2016 Sep; 33(9):1175-84. PubMed ID: 27349252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
    Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
    Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian hyperstimulation syndrome: distinction between local and systemic disease.
    Cobellis L; Pecori E; Stradella L; De Lucia E; Messalli EM; Cobellis G
    Gynecol Endocrinol; 2003 Apr; 17(2):95-9. PubMed ID: 12737669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ascites in the ovarian hyperstimulation syndrome does not originate from the ovary.
    Yarali H; Fleige-Zahradka BG; Yuen BH; McComb PF
    Fertil Steril; 1993 Mar; 59(3):657-61. PubMed ID: 8458471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian hyperstimulation syndrome: imperatives for the emergency physician.
    Rutkowski A; Dubinsky I
    J Emerg Med; 1999; 17(4):669-72. PubMed ID: 10431959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.